SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-23-054063
Filing Date
2023-11-21
Accepted
2023-11-20 19:52:56
Documents
5
Effectiveness Date
2023-11-21

Document Format Files

Seq Description Document Type Size
1 S-8 ef20014941_s8.htm S-8 51734
2 EXHIBIT 5.1 ef20014941_ex5-1.htm EX-5.1 11273
3 EXHIBIT 23.1 ef20014941_ex23-1.htm EX-23.1 1943
4 EXHIBIT 107 ef20014941_ex107.htm EX-FILING FEES 24278
5 image00001.jpg GRAPHIC 35313
  Complete submission text file 0001140361-23-054063.txt   139205
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275673 | Film No.: 231424192
SIC: 2834 Pharmaceutical Preparations